Risk Factors for Refractory Immune Checkpoint Inhibitor-related Pneumonitis in Patients With Lung Cancer: Erratum (vol 46, year 2023, page 120)-MedSci.cn - 梅斯（MedSci）

Risk Factors for Refractory Immune Checkpoint Inhibitor-related Pneumonitis in Patients With Lung Cancer: Erratum (vol 46, year 2023, page 120)

Tan, P; Huang, W; He, X

JOURNAL OF IMMUNOTHERAPY, 2023; 46 (3): 120

科室
- - 订阅+
  - 更多科室
工具
服务